Search Results - "Gibowski, Severine"
-
1
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study
Published in Clinical infectious diseases (19-03-2018)“…Failure to achieve sustained virological response (SVR) with hepatitis C virus (HCV) direct-acting antiviral (DAA)-based regimens is commonly associated with…”
Get full text
Journal Article -
2
Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance
Published in Journal of antimicrobial chemotherapy (01-06-2023)“…Abstract Background In a 4 days/week (4/7 days) maintenance strategy (ANRS-170 QUATUOR trial), the virological impact of an intermittent strategy was assessed…”
Get full text
Journal Article -
3
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study
Published in Journal for immunotherapy of cancer (22-08-2024)“…BackgroundImmune checkpoint inhibitors (ICIs) have been a major advance in cancer management. However, we still lack prospective real-world data regarding…”
Get full text
Journal Article -
4
Implementation of a centralized pharmacovigilance system in academic pan‐European clinical trials: Experience from EU‐Response and conect4children consortia
Published in British journal of clinical pharmacology (01-04-2023)“…Setting‐up a high quality, compliant and efficient pharmacovigilance (PV) system in multi‐country clinical trials can be more challenging for academic sponsors…”
Get full text
Journal Article -
5
A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial
Published in The lancet HIV (01-02-2022)“…Intermittent (on 4 days per week) antiretroviral therapy (ART) for patients with HIV-1 might be more convenient, better tolerated, and cheaper than continuous…”
Get full text
Journal Article -
6
Plasma concentrations of antiretroviral drugs in a successful 4-days-a-week maintenance treatment strategy in HIV-1 patients (ANRS 170-Quatuor trial)
Published in Journal of antimicrobial chemotherapy (03-06-2024)“…Charaterization of the plasma concentrations of antiretrovirals in a 4-days-a-week maintenance treatment strategy in the ANRS-170-QUATUOR study. Patients were…”
Get full text
Journal Article -
7
Fat gain differs by sex and hormonal status in persons living with suppressed HIV switched to raltegravir/etravirine
Published in AIDS (London) (01-10-2020)“…Fat gain is reported in integrase strand transfer inhibitors exposed persons living with HIV. We investigated in 165 persons living with HIV (117 men/48…”
Get full text
Journal Article -
8
Pharmacological data of a successful 4‐days‐a‐week regimen in HIV antiretroviral therapy (ANRS 162‐4D trial)
Published in British journal of clinical pharmacology (01-04-2021)“…Introduction Few data are available on plasma concentrations of antiretroviral therapy (ARV) during intermittent treatment. Objective To compare plasma…”
Get full text
Journal Article -
9
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial
Published in AIDS research and human retroviruses (01-01-2017)“…Lenalidomide, an oral immunomodulating agent, has shown promising activity in HIV-infected individuals with Kaposi's sarcoma (KS). This single-arm,…”
Get more information
Journal Article -
10
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study
Published in Journal of antimicrobial chemotherapy (01-09-2019)“…Abstract Background Dual therapy combining integrase inhibitors and NNRTIs represents a promising regimen in ageing HIV-infected individuals with long exposure…”
Get full text
Journal Article -
11
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design
Published in The Lancet infectious diseases (01-10-2024)“…Increased rates of sexually transmitted infections (STIs) are reported among men who have sex with men (MSM) and new interventions are needed. We aimed to…”
Get full text
Journal Article -
12
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study-authors' response
Published in Journal of antimicrobial chemotherapy (01-12-2020)Get full text
Journal Article -
13
Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial
Published in The Lancet regional health. Europe (01-10-2024)“…Mpox was first reported in France on May 19 and third-generation live Modified Vaccinia Ankara (MVA-BN) vaccination of multiple-partner men who have sex with…”
Get full text
Journal Article -
14
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial
Published in Journal of antimicrobial chemotherapy (01-03-2018)“…Intermittent treatment could improve the convenience, tolerability and cost of ART, as well as patients' quality of life. We conducted a 48 week multicentre…”
Get full text
Journal Article -
15
Retreatment with sofosbuvir plus grazoprevir plus elbasvir plus ribavirin of patients with Hepatitis C virus Genotype 1 or 4 with RASs at failure of a sofosbuvir plus ledipasvir or plus daclatasvir or plus simeprevir regimen (ANRS HC34 REVENGE study)
Published in Hepatology (Baltimore, Md.) (2017)“…67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - Boston, MA - 2016-11-11…”
Get full text
Journal Article -
16
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks
Published in Virologie (Montrouge, France) (01-02-2023)Get more information
Journal Article -
17
Low incidence of acute rejection within 6 months of kidney transplantation in HIV‐infected recipients treated with raltegravir: the Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS) 153 TREVE trial
Published in HIV medicine (01-03-2019)“…Objectives High rates of clinical acute rejection after kidney transplantation have been reported in people living with HIV (PLHIV), probably as a consequence…”
Get full text
Journal Article -
18
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks
Published in Virologie (Montrouge, France) (01-02-2023)Get more information
Journal Article -
19
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
Published in The lancet HIV (01-09-2017)“…Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour. We…”
Get full text
Journal Article -
20
On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
Published in The lancet HIV (01-02-2020)“…ANRS IPERGAY found that on-demand pre-exposure prophylaxis (PrEP) with oral tenofovir disoproxil fumarate plus emtricitabine was associated with an 86%…”
Get full text
Journal Article